Annual Meeting, held December 6-9, 2025, in Orlando, Florida, showcased groundbreaking clinical advances in multiple myeloma treatment from leading biopharmaceutical companies. The conference ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

From fully unplugging from work when they got off the clock to following through on plans, these are things people in the ...

Will Hall was pumping a Tulane parasol as he led a second line into the Glazer Family Club inside Yulman Stadium on Tuesday ...

Cancer Research UK's Centre for Drug Development is sponsoring and conducting the phase I/II clinical trial of ALETA-001, the lead agent in Aleta Biotherapeutics' portfolio. Additional clinical trial ...

Phase 2 Clinical Data Highlights: Hemab's Phase 2 study of sutacimig (N=34) is intended to address a profound gap in care for GT as there are currently no effective prophylactic treatment options.

BostonGene, developer of the leading AI foundation model for cancer and the immune system, today announced seven abstracts have been accepted for presentation at the San Antonio Breast Cancer ...

Objectives To explore the patient and informal-carer reported factors that influence prescribing decisions in the management of borderline personality disorder (BPD). Design The study employed a ...

We did it! Here are the responses to some questions! What New Year’s resolution do you want your school’s coaching staff to ...

To accommodate these changes, the department reduced the number of organic chemistry seats to make sure all students in CHEM ...

The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...

China Eastern has made history by starting the world's new longest one-stop scheduled passenger service. On December 4, it ...